Leukemia Research
Volume 33, Issue 12 , Pages 1609-1614 , December 2009

Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk

  • H. Dean Hosgood III

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States
    • Corresponding Author InformationCorresponding author at: National Cancer Institute, Division of Cancer Epidemiology and Genetics, Occupational and Environmental Epidemiology Branch, 6120 Executive Blvd., EPS 8118, MCS 7240, Bethesda, MD 20892-7240, United States. Tel.: +1 301 594 4649; fax: +1 301 402 1819.
    • ,
  • Dalsu Baris

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States
    • ,
  • Yawei Zhang

      Affiliations

    • Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, CT, United States
    • ,
  • Sonja I. Berndt

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States
    • ,
  • Idan Menashe

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States
    • ,
  • Lindsay M. Morton

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States
    • ,
  • Kyoung-Mu Lee

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States
    • ,
  • Meredith Yeager

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States
    • ,
  • Shelia H. Zahm

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States
    • ,
  • Stephen Chanock

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States
    • ,
  • Tongzhang Zheng

      Affiliations

    • Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, CT, United States
    • ,
  • Qing Lan

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States

Received 31 December 2008 ,Revised 11 March 2009 ,Accepted 12 March 2009.

References 

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(January (1)):43–66
  2. Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer. 2007;7(August (8)):585–598
  3. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281(August (5381)):1322–1326
  4. Hajra KM, Liu JR. Apoptosome dysfunction in human cancer. Apoptosis. 2004;9(November (6)):691–704
  5. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci. 1997;22(August (8)):299–306
  6. De Roos A, Baris D, Weiss N, Herrinton L, Multiple myeloma . In:  Schottenfeld D,  Fraumeni JF editor. Cancer epidemiology and prevention. 3rd ed.. New York: Oxford University Press; 2006;
  7. Alexander DD, Mink PJ, Adami HO, Cole P, Mandel JS, Oken MM, et al. Multiple myeloma: a review of the epidemiologic literature. Int J Cancer. 2007;120(Suppl. 12):40–61
  8. Landgren O, Linet MS, McMaster ML, Gridley G, Hemminki K, Goldin LR. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case–control study. Int J Cancer. 2006;118(June (12)):3095–3098
  9. Hemminki K, Li X, Czene K. Familial risk of cancer: data for clinical counseling and cancer genetics. Int J Cancer. 2004;108(January (1)):109–114
  10. Zheng C, Huang D, Liu L, Bjorkholm M, Holm G, Yi Q, et al. Cytotoxic T-lymphocyte antigen-4 microsatellite polymorphism is associated with multiple myeloma. Br J Haematol. 2001;112(January (1)):216–218
  11. Zheng C, Huang D, Liu L, Wu R, Bergenbrant GS, Osterborg A, et al. Interleukin-10 gene promoter polymorphisms in multiple myeloma. Int J Cancer. 2001;95(May (3)):184–188
  12. Brown EE, Lan Q, Zheng T, Zhang Y, Wang SS, Hoar-Zahm S, et al. Common variants in genes that mediate immunity and risk of multiple myeloma. Int J Cancer. 2007;120(12):2715–2722
  13. Lincz LF, Kerridge I, Scorgie FE, Bailey M, Enno A, Spencer A. Xenobiotic gene polymorphisms and susceptibility to multiple myeloma. Haematologica. 2004;89(May (5)):628–629
  14. Kang SH, Kim TY, Kim HY, Yoon JH, Cho HI, Yoon SS, et al. Protective role of CYP1A1*2A in the development of multiple myeloma. Acta Haematol. 2008;119(1):60–64
  15. Ortega MM, Nascimento H, Melo MB, Teori MT, Costa FF, Lima CS. Polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta1 (GSTT1) genes in multiple myeloma. Acta Haematol. 2003;109(2):108–109
  16. Velangi MR, Matheson EC, Morgan GJ, Jackson GH, Taylor PR, Hall AG, et al. DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma. Carcinogenesis. 2004;25(October (10)):1795–1803
  17. Hayden PJ, Tewari P, Morris DW, Staines A, Crowley D, Nieters A, et al. Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma. Hum Mol Genet. 2007;16(December (24)):3117–3127
  18. Hosgood HD, Baris D, Zhang Y, Zhu Y, Zheng T, Yeager M, et al. Caspase polymorphisms and genetic susceptibility to multiple myeloma. Hematol Oncol. 2008;26(3):148–151
  19. Garcia-Closas M, Egan KM, Abruzzo J, Newcomb PA, Titus-Ernstoff L, Franklin T, et al. Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev. 2001;10(June (6)):687–696
  20. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2004;74(January (1)):106–120
  21. Chen BE, Sakoda LC, Hsing AW, Rosenberg PS. Resampling-based multiple hypothesis testing procedures for genetic case–control association studies. Genet Epidemiol. 2006;30(September (6)):495–507
  22. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol. 1995;12(September (5)):921–927
  23. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70(February (2)):425–434
  24. Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF. Apoptosis and lung cancer: a review. J Cell Biochem. 2003;88(April (5)):885–898
  25. Lan Q, Zheng T, Chanock S, Zhang Y, Shen M, Wang SS, et al. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis. 2007;28(4):823–827
  26. Helmbrecht K, Zeise E, Rensing L. Chaperones in cell cycle regulation and mitogenic signal transduction: a review. Cell Prolif. 2000;33(December (6)):341–365
  27. Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, et al. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer. Breast Cancer Res. 2008;10(March (2)):R22
  28. Lindsey JC, Lusher ME, Strathdee G, Brown R, Gilbertson RJ, Bailey S, et al. Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours. Int J Cancer. 2006;118(January (2)):346–352
  29. Starczynski J, Pepper C, Pratt G, Hooper L, Thomas A, Milligan D, et al. Common polymorphism G(−248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated. J Clin Oncol. 2005;23(March (7)):1514–1521
  30. Skogsberg S, Tobin G, Krober A, Kienle D, Thunberg U, Aleskog A, et al. The G(−248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia. Leukemia. 2006;20(January (1)):77–81
  31. Wojcik I, Szybka M, Golanska E, Rieske P, Blonski JZ, Robak T, et al. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias. Neoplasma. 2005;52(4):318–324
  32. Meylan E, Tschopp J. The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci. 2005;30(March (3)):151–159
  33. Devin A, Cook A, Lin Y, Rodriguez Y, Kelliher M, Liu Z. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity. 2000;12(April (4)):419–429
  34. Morgan GJ, Adamson PJ, Mensah FK, Spink CF, Law GR, Keen LJ, et al. Haplotypes in the tumour necrosis factor region and myeloma. Br J Haematol. 2005;129(May (3)):358–365
  35. Zheng C, Huang DR, Bergenbrant S, Sundblad A, Osterborg A, Bjorkholm M, et al. Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Haematol. 2000;109(April (1)):39–45
  36. Brown EE, Lan Q, Zheng T, Zhang Y, Wang SS, Hoar-Zahm S, et al. Common variants in genes that mediate immunity and risk of multiple myeloma. Int J Cancer. 2007;120(June (12)):2715–2722
  37. Wacholder S, Chanock S, Garcia-Closas M, El GL, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96(March (6)):434–442
  38. Bhatti P, Sigurdson AJ, Wang SS, Chen J, Rothman N, Hartge P, et al. Genetic variation and willingness to participate in epidemiologic research: data from three studies. Cancer Epidemiol Biomarkers Prev. 2005;14(October (10)):2449–2453

PII: S0145-2126(09)00136-2

doi: 10.1016/j.leukres.2009.03.013

Leukemia Research
Volume 33, Issue 12 , Pages 1609-1614 , December 2009

Article Tools

* Image Usage & Resolution